Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Recent & Breaking News (OTCQX:MRVFF)

Miravo Healthcare(TM) Announces the Canadian Commercial Launch of Blexten® for Patients 4 Years of Age and Older*

Business Wire March 1, 2022

Miravo Healthcare(TM) Announces Summary Judgment Ruling by the United States District Court for the District of New Jersey

Business Wire February 28, 2022

Miravo Healthcare(TM) to Present at Q1 Virtual Investor Summit

Business Wire February 28, 2022

Miravo Healthcare(TM) Named to 2022 OTCQX Best 50

Business Wire January 24, 2022

Miravo Healthcare(TM) Announces Participation at the H.C. Wainwright Bioconnect Conference

Business Wire January 6, 2022

Miravo Healthcare(TM) Presents at the SNN Network Canada Virtual Event

Business Wire November 24, 2021

Miravo Healthcare(TM) to Host Investor Webcast on December 2, 2021 at 2:00 p.m. ET

Business Wire November 18, 2021

Miravo Healthcare(TM) Announces Third Quarter 2021 Results

Business Wire November 15, 2021

Miravo Healthcare(TM) Announces Third Quarter 2021 Results Release Date and Conference Call Details

Business Wire November 1, 2021

Miravo Healthcare(TM) Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference

PR Newswire September 7, 2021

Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea

PR Newswire July 29, 2021

Miravo Healthcare(TM) Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets

Canada NewsWire December 21, 2020

Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare(TM)

Canada NewsWire December 18, 2020

Nuvo Pharmaceuticals® Announces Third Quarter 2020 Results

PR Newswire November 16, 2020

Nuvo Pharmaceuticals(TM) Announces Third Quarter 2020 Results Release Date and Conference Call Details

Canada NewsWire November 2, 2020

Growth Company Investor Presentations Now Available for On-Demand Viewing

Canada NewsWire October 12, 2020

Live Growth Opportunities Investor Conference October 8th

Canada NewsWire October 5, 2020

Nuvo Pharmaceuticals® to Webcast Live at VirtualInvestorConferences.com October 8th

Canada NewsWire October 5, 2020

Virtual Conference for Life Sciences Companies Broadcast Live September 17th, 2020

GlobeNewswire September 14, 2020

Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th

Canada NewsWire September 14, 2020